Lindemans CA, Leen AM, Boelens JJ. How I treat adenovirus in hematopoietic stem cell transplant recipients. Blood. 2010;116:5476–85.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matthes-Martin S, Feuchtinger T, Shaw PJ, Engelhard D, Hirsch HH, Cordonnier C, et al. European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL-4 (2011). Transpl Infect Dis 2012;14:555–63.

Article  CAS  PubMed  Google Scholar 

Lion T. Adenovirus infections in immunocompetent and immunocompromised patients. Clin Microbiol Rev. 2014;27:441–62.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hiwarkar P, Kosulin K, Cesaro S, Mikulska M, Styczynski J, Wynn R, et al. Management of adenovirus infection in patients after haematopoietic stem cell transplantation: state-of-the-art and real-life current approach: a position statement on behalf of the Infectious Diseases Working Party of the European Society of Blood and Marrow Transplantation. Rev Med Virol. 2018;28:e1980.

Article  PubMed  Google Scholar 

Cesaro S, Berger M, Tridello G, Mikulska M, Ward KN, Ljungman P, et al. A survey on incidence and management of adenovirus infection after allogeneic HSCT. Bone Marrow Transplant. 2019;54:1275–80.

Article  PubMed  Google Scholar 

Czyzewski K, Styczynski J, Giebel S, Fraczkiewicz J, Salamonowicz M, Zajac-Spychala O, et al. Age-dependent determinants of infectious complications profile in children and adults after hematopoietic cell transplantation: lesson from the nationwide study. Ann Hematol. 2019;98:2197–211.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Styczynski J. Looking to the CAR-T future: vaccination, outpatient therapy, artificial intelligence and expanding indications. Acta Haematol Pol. 2022;53:151–52.

Google Scholar 

Kampouri E, Little JS, Rejeski K, Manuel O, Hammond SP, Hill JA. Infections after chimeric antigen receptor (CAR)-T-cell therapy for hematologic malignancies. Transpl Infect Dis. 2023:e14157 https://doi.org/10.1111/tid.14157.

Zajac-Spychala O, Pieczonka A, Wachowiak J, Fraczkiewicz J, Salamonowicz M, Kalwak K, et al. Adenovirus infection among pediatric patients with cancer and in pediatric recipients of hematopoietic stem cell: a multicenter nationwide study. J Med Virol. 2020;92:3187–93.

Article  CAS  PubMed  Google Scholar 

Papanicolaou GA, Dvorak CC, Dadwal S, Maron G, Prasad VK, Giller R, et al. Practice patterns and incidence of adenovirus infection in allogeneic hematopoietic cell transplant recipients: multicenter survey of transplant centers in the United States. Transpl Infect Dis. 2020;22:e13283.

Article  PubMed  Google Scholar 

Gonzalez-Vicent M, Verna M, Pochon C, Chandak A, Vainorius E, Brundage T, et al. Current practices in the management of adenovirus infection in allogeneic hematopoietic stem cell transplant recipients in Europe: the AdVance study. Eur J Haematol. 2019;102:210–17.

Article  PubMed  PubMed Central  Google Scholar 

Sedlacek P, Petterson T, Robin M, Sivaprakasam P, Vainorius E, Brundage T, et al. Incidence of adenovirus infection in hematopoietic stem cell transplantation recipients: findings from the AdVance Study. Biol Blood Marrow Transplant. 2019;25:810–18.

Article  PubMed  Google Scholar 

Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974;18:295–304.

Article  CAS  PubMed  Google Scholar 

Iacobelli S. Suggestions on the use of statistical methodologies in studies of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2013;48:S1–37.

Article  PubMed  Google Scholar 

Klein JP, Moeschberger ML. Survival analysis: techniques for censored and truncated data. New York: Springer-Verlag; 2003.

Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Control Clin Trials. 1996;17:343–6.

Article  CAS  PubMed  Google Scholar 

Al-Heeti OM, Cathro HP, Ison MG. Adenovirus infection and transplantation. Transplantation. 2022;106:920–27.

Article  CAS  PubMed  Google Scholar 

Cesaro S. Adenovirus infection in allogeneic hematopoietic cell transplantation. Transpl Infect Dis. 2023;25:e14173.

Article  PubMed  Google Scholar 

Passweg JR, Baldomero H, Ciceri F, Corbacioglu S, de la Camara R, Dolstra H, et al. Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A Report from the EBMT Activity Survey. Bone Marrow Transplant. 2023;58:647–58.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ljungman P, Brand R, Einsele H, Frassoni F, Niederwieser D, Cordonnier C. Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis. Blood. 2003;102:4255–60.

Article  CAS  PubMed  Google Scholar 

Ljungman P, Tridello G, Pinana JL, Ciceri F, Sengeloev H, Kulagin A, et al. Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry. Front Immunol. 2023;14:1125824.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pikkel-Geva HZ, Grisariu S, Rivkin M, Stepensky P, Strahilevitz J, Averbuch D, et al. High rate of adenovirus detection in gastrointestinal biopsies of symptomatic stem cell transplant recipients. Clin Transplant. 2023;37:e15098.

Article  PubMed  Google Scholar 

Cesaro S, Porta F. Adenovirus infection in pediatric hematopoietic cell transplantation: a challenge still open for survival. J Clin Med. 2022;11:4827.

Styczynski J, Tridello G, Koster L, Knelange N, Wendel L, van Biezen A, et al. Decrease of lethal infectious complications in the context of causes of death (COD) after hematopoietic cell transplantation: COD-2 and COD-1 study of the Infectious Diseases Working Party EBMT. Bone Marrow Transplant. 2023;58:881–92.

Article  CAS  PubMed  Google Scholar 

Deambrosis D, Davies E, Turner A, Guiver M, Bonney D, Campbell H, et al. Burden of adenoviraemia predicts survival in paediatric recipients of allogeneic haematopoietic stem cell transplant. J Clin Virol. 2020;127:104373.

Article  CAS  PubMed  Google Scholar 

Lee YJ, Fang J, Zavras PD, Prockop SE, Boulad F, Tamari R, et al. Adenovirus viral kinetics and mortality in ex vivo T cell-depleted hematopoietic cell transplant recipients with adenovirus infection from a single center. J Infect Dis. 2020;222:1180–87.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Inamoto Y, Takeda W, Hirakawa T, Sakaguchi H, Nakano N, Uchida N, et al. Adenovirus disease after hematopoietic cell transplantation: a Japanese transplant registry analysis. Am J Hematol. 2022;97:1568–79.

Article  PubMed  Google Scholar